/ /

  • linkedin
  • Increase Font
  • Sharebar

    Laser injury requires second opinion

    No treatment recommended due to stable retinal/RPE remodeling

    Figure 1A

     

     

     


     

     

     

     

     

     

     

     

     

    A 56 year-old male patient came into the clinic recently for a second opinion concerning a previous injury to his right eye. A high-powered commercial laser in a physics laboratory was the source of the injury in 2005. He is currently a full-time spectacle lens wearer. The medical history is significant for the following: appendectomy 1980; systemic hypertension treated and controlled with oral medications for the past 6-7 years; hyperlipidemia treated with Lipitor (atorvastatin calcium, Pfizer) for 3 years. He is a former smoker, but a pack-year calculation was not recorded. He reports no known allergies. Regarding his family history, he reports that his mother has been treated for liver cancer. 

    Figure 1B

    Pertinent clinical findings include:

    • Visual acuity: OD 5/25 (EV), OS 20/20

    • IOP: 20/21 mm Hg OD/OS

    • The anterior segment was unremarkable, and visual field was full to confrontation testing.

    • EOMs: no restrictions.

    Figure 2

    The figures show the fundus appearance of the right and left eyes (Figures 1 and 2). In addition, an OCT characterized carefully the architectural changes at the level of the outer and inner retina at the macula (Figures 3 and 4).

    Because this represents stable retinal/RPE remodeling, no treatment was recommended. He will continue to be followed, recommended to wear safety glasses, and to observe laser safety protocols as recommended by manufacturers.ODT


    Figure 3Figure 4

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Optometry Times A/V